Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Homo sapiens | glycoprotein hormones, alpha polypeptide | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Toxoplasma gondii | intraflagellar transport protein 172, putative | glycoprotein hormones, alpha polypeptide | 116 aa | 94 aa | 26.6 % |
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | retinoid-x-receptor (RXR) | 0.0147 | 0.3981 | 0.1071 |
Loa Loa (eye worm) | hypothetical protein | 0.0131 | 0.3259 | 0.3259 |
Loa Loa (eye worm) | hypothetical protein | 0.0131 | 0.3259 | 0.3259 |
Brugia malayi | Cytochrome P450 family protein | 0.0069 | 0.0422 | 0.0422 |
Loa Loa (eye worm) | hypothetical protein | 0.0131 | 0.3259 | 0.3259 |
Brugia malayi | hypothetical protein | 0.0147 | 0.3981 | 0.3981 |
Loa Loa (eye worm) | hypothetical protein | 0.0131 | 0.3259 | 0.3259 |
Loa Loa (eye worm) | hypothetical protein | 0.0131 | 0.3259 | 0.3259 |
Brugia malayi | Nuclear hormone receptor-like 1 | 0.0147 | 0.3981 | 0.3981 |
Brugia malayi | ecdysone receptor | 0.0131 | 0.3259 | 0.3259 |
Loa Loa (eye worm) | hypothetical protein | 0.0131 | 0.3259 | 0.3259 |
Loa Loa (eye worm) | hypothetical protein | 0.0131 | 0.3259 | 0.3259 |
Loa Loa (eye worm) | hypothetical protein | 0.0131 | 0.3259 | 0.3259 |
Brugia malayi | orphan nuclear receptor NR2E1 | 0.0131 | 0.3259 | 0.3259 |
Brugia malayi | Nuclear hormone receptor-like 1 | 0.0147 | 0.3981 | 0.3981 |
Loa Loa (eye worm) | hypothetical protein | 0.0131 | 0.3259 | 0.3259 |
Brugia malayi | nuclear hormone receptor | 0.0131 | 0.3259 | 0.3259 |
Brugia malayi | nuclear receptor NHR-67 | 0.0131 | 0.3259 | 0.3259 |
Loa Loa (eye worm) | nuclear receptor nhr-7B | 0.0131 | 0.3259 | 0.3259 |
Loa Loa (eye worm) | nuclear receptor NHR-67 | 0.0131 | 0.3259 | 0.3259 |
Echinococcus granulosus | nuclear receptor subfamily 1 group D | 0.0147 | 0.3981 | 0.1071 |
Loa Loa (eye worm) | hypothetical protein | 0.0131 | 0.3259 | 0.3259 |
Brugia malayi | nuclear hormone receptor family member nhr-6 | 0.0131 | 0.3259 | 0.3259 |
Loa Loa (eye worm) | hypothetical protein | 0.0147 | 0.3981 | 0.3981 |
Loa Loa (eye worm) | hypothetical protein | 0.0131 | 0.3259 | 0.3259 |
Schistosoma mansoni | ecdysone-induced protein 78c (dr-78) | 0.0147 | 0.3981 | 0.1071 |
Loa Loa (eye worm) | nuclear hormone receptor | 0.0131 | 0.3259 | 0.3259 |
Loa Loa (eye worm) | hypothetical protein | 0.0147 | 0.3981 | 0.3981 |
Loa Loa (eye worm) | hypothetical protein | 0.0147 | 0.3981 | 0.3981 |
Brugia malayi | nuclear receptor RXR | 0.0147 | 0.3981 | 0.3981 |
Brugia malayi | nuclear hormone receptor family member odr-7 | 0.0131 | 0.3259 | 0.3259 |
Loa Loa (eye worm) | hypothetical protein | 0.0147 | 0.3981 | 0.3981 |
Loa Loa (eye worm) | hypothetical protein | 0.0131 | 0.3259 | 0.3259 |
Brugia malayi | nuclear receptor RXR | 0.0131 | 0.3259 | 0.3259 |
Brugia malayi | nuclear receptor NHR-88 | 0.0131 | 0.3259 | 0.3259 |
Brugia malayi | Nuclear hormone receptor E75 | 0.0131 | 0.3259 | 0.3259 |
Brugia malayi | hypothetical protein | 0.0131 | 0.3259 | 0.3259 |
Loa Loa (eye worm) | hypothetical protein | 0.0147 | 0.3981 | 0.3981 |
Brugia malayi | conserved hypotetical protein | 0.0131 | 0.3259 | 0.3259 |
Brugia malayi | hypothetical protein | 0.0147 | 0.3981 | 0.3981 |
Echinococcus multilocularis | nuclear receptor subfamily 1 group D | 0.0147 | 0.3981 | 0.1071 |
Brugia malayi | Nuclear hormone receptor E75 | 0.0131 | 0.3259 | 0.3259 |
Brugia malayi | nuclear receptor subfamily 1, group D, member 1, putative | 0.0131 | 0.3259 | 0.3259 |
Brugia malayi | tailless protein | 0.0131 | 0.3259 | 0.3259 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0069 | 0.0422 | 0.0422 |
Loa Loa (eye worm) | nuclear hormone receptor-like 1 | 0.0147 | 0.3981 | 0.3981 |
Brugia malayi | hypothetical protein | 0.0131 | 0.3259 | 0.3259 |
Loa Loa (eye worm) | hypothetical protein | 0.0131 | 0.3259 | 0.3259 |
Loa Loa (eye worm) | DR-78 | 0.0131 | 0.3259 | 0.3259 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 3.5481 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 9.285 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 10 uM | PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 11.2202 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] | ChEMBL. | No reference |
Potency (functional) | 13.1154 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 20.5962 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 23.1093 uM | PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (binding) | = 25.1189 um | PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)] | ChEMBL. | No reference |
Potency (functional) | 25.1189 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | 25.1189 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of binding or entry into cells for Lassa Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249] | ChEMBL. | No reference |
Potency (functional) | 29.0929 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 35.4813 um | PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 35.4813 um | PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 39.8107 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 | ||
Homo sapiens | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.